Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tc-99m tilmanocept
DRUG
2 trials
Sponsors
Washington University School of Medicine
, John O. Prior
Conditions
Central Nervous System Neoplasms
Central Nervous System Tumor
Melanoma
Early Phase 1
Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma
Terminated
NCT04663126
John O. Prior
Melanoma
Start: 2021-02-01
End: 2023-06-19
Updated: 2023-12-13
Phase 1
Mapping Draining Lymph Nodes in CNS Malignancies
Terminated
NCT04096716
Washington University School of Medicine
Central Nervous System Neoplasms, Central Nervous System Tumor
Start: 2019-12-03
End: 2022-04-30
Updated: 2023-12-21
Related Papers
Utility of [<sup>99m</sup>Tc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility study.
2025-09-06